Hanlin Yin

MD, PhD
Rheumatology

[NEJM @NEJM]

A 32-year-old man presented with a 4-month history of recurrent abscesses and a 3-day history of a skin lesion on his face. On examination, a skin ulcer with a violaceous border was seen on the right lower portion of the face. Read the full clinical case: https://t.co/q6w6kM9DzC

[Hanlin Yin @hanlinyinMD]

HOT off the press! Thrilled to share that our case has been published in @NEJM Grateful for all the support received.😄 https://t.co/4yysKhQBaG

#PyodermaGangrenosum
#autoinflammatory
#rheumtwitter
#dermtwitter
#MedTwitter

[Hanlin Yin @hanlinyinMD]

@monicayangMD Really great Glad to find your twitter btw

[Take a Pain Check Foundation @takeapaincheck]

Thank you so much for stopping by and winning Rheumy! @hanlinyinMD #ACR23

[Hanlin Yin @hanlinyinMD]

@Janetbirdope Perhaps the nailfold abnormalities are more clearly shown in this image for your reference.😉 https://t.co/LJmnt25fnN

[ClinRheumatol @ClinRheumatol]

Adie’s tonic pupil in primary Sjögren syndrome
✅a rare neurological disorder characterized by enlargement of the pupil with poor reaction to light and light-near dissociation
✅ciliary ganglionitis might be the underlying mechanism in #SjögrenSyndrome
👉https://t.co/u9h46j0Rgu

[Hanlin Yin @hanlinyinMD]

Delighted to publish our image in @CMAJ, to facilitate early recognition of #SystemicSclerosis #scleroderma #SSc

[CMAJ @CMAJ]

Systemic sclerosis:
Puffy fingers, Raynaud phenomenon and abnormal nail fold capillaries are typical features of the early phase of systemic sclerosis.
➡️ https://t.co/GXwPylepTg
(earn CPD credits)

[ACR_Journals @ACR_Journals]

Endothelial IFN-1 signature distinguishes systemic sclerosis skin subtypes and disease progression and may contribute to vasculopathy and fibrosis

In Arthritis & Rheumatology
https://t.co/m6kRf7zSTs
@hanlinyinMD

[The Lancet Rheumatology @TheLancetRheum]

NEW VIEWPOINT—Gemma Lepri and colleagues discuss the role of #ultrasound in evaluating skin involvement in patients with #SystemicSclerosis
https://t.co/B7xYCe9fKU @allanore @iaiaraia @delgaldoFrances @sclerodermaUM @MatucciMarco

[Hanlin Yin @hanlinyinMD]

@Janetbirdope early progressive diffuse SSc. RNAP III or Scl70 most likely. This patient is likely to progress as he is probably at an active stage with high inflammatory reactants. Hints from the redness of the forearm.

[Hanlin Yin @hanlinyinMD]

Really informative!

[Laurent ARNAUD @Lupusreference]

FREE download at: https://t.co/wDTpaT4i5T
⬆️
New targeted treatments in #Lupus

[Hanlin Yin @hanlinyinMD]

Very Useful

[Association of Women in Rheumatology @AWIRGROUP]

Knowing how to interpret PFTs is important. Dr Steen gives us this pearl #AWIR summit.

[Association of Women in Rheumatology @AWIRGROUP]

Dr Steen sums up therapy for PSSc ILD here #WomeninRheum Summit today. #AWIR educating everyone everyday everywhere. Look for our annual conference registration for your virtual participation 12-15 Aug. Go to https://t.co/fBCpfXruPl.

[Ashima Makol MD @AshimaMakol]

There is a very nice handout from @scleroderma on hand and face excercises in #Scleroderma that I use a lot for my patients! It works!! @Fscleroderma #SclerodermaAwarenessMonth

[Hanlin Yin @hanlinyinMD]

@rheum_cat Yeah! Have an obsession to watch live stream😅

[Hanlin Yin @hanlinyinMD]

#ACR20 Hi from Shanghai at 3am🥱Sleepy but super excited!!

[Hanlin Yin @hanlinyinMD]

@rheum_cat Thanks for the guide! I'm wondering when the replay will be available? 13hrs time difference😅

[Hanlin Yin @hanlinyinMD]

Our latest review in #CurrentRheumatologyReports on insights into recent SSc research. https://t.co/KFA8GJnfJd #SystemicSclerosis #Scleroderma